The volunteers were provided with Nanocovax, a Covid-19 vaccine developed by Nanogen Pharmaceutical Biotechnology JSC.
The first person was provided with Nanocovax vaccine at the Military Medical Academy this morning, December 17.
Dr To Minh Si, Nanogen Pharmaceutical Biotechnology JSC’s director for research and development, said that the volunteers have to stay at the immunisation room for at least 30 minutes for monitoring. They were instructed how to recognise possible reactions after the injection. The interval between the first and second injection will be 28 days.
The participants will be closely monitored for 56 days and periodic follow-up evaluations will be followed for six months from the first injection.
Based on the vaccine efficiency assessment of the first three during the 72 hours following vaccination, the researchers will determine the correct dosage for the remainder of the total 60 participants.
People who are selected for the vaccine trial must have good health and be aged between 18 and 50.
Lieutenant general, Do Quyet, director of the Military Medical Academy, said that safety is the first priority in the Covid-19 vaccine test. The academy set up 10 groups that are in charge of dealing with possible reactions after the vaccination.
